Donate to PCRI: https://pcri.org/donate/'>https://pcri.org/donate/
For more information, visit https://pcri.org

Videos For Further Information:
PARP Inhibitors:    • New FDA Approved PARP Inhibitor: Talz...  
PSMA:    • PSMA & NewlyDiagnosed #ProstateCance...  
Active Surveillance:    • Active Surveillance 101 | Ask a Prost...  
PROSTOX:    • IMRT vs. SBRT & Reducing Radiation To...  
Zepbound:    • 2023 Update: Wegovy, Ozempic, & Zepbo...  

1:08 What are the new PARP Inhibitors, Talzenna and Akegga?
2:18 How effective has PSMA been at helping patients delay chemotherapy?
5:08 What was the state of active surveillance in 2023?
5:56 What is Prostox and can it apply to spot radiation?
7:49 What was the state of Pluvicto as a treatment in 2023?
10:02 How have Zepbound and other semaglutides affected prostate cancer?
11:39 How has prostate cancer treatment been affected by all these new developments?
13:26 Alex's conclusions

Don't know your stage? Take the quiz: visit http://www.prostatecancerstaging.org

To learn more about prostate cancer, visit http://www.pcri.org

Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) notforprofit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive betterindividualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 954617875 and qualifies for maximum charitable gift deductions by individual donors.